3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
111
Neoplasms
8
Neoplasm Metastasis
6
Carcinoma, Intraductal, Noninfiltrating
6
Breast Carcinoma In Situ
4
Arthralgia
4
Advanced Breast Cancer
4
Osteoporosis
2
Multiple Endocrine Neoplasia Type 1
2
Breast Neoplasms, Male
2
Breast Cancer Metastatic
2
Triple Negative Breast Neoplasms
1
Sexual Dysfunction, Physiological
1
Seizures
1
Recurrence
1
Quality of Life
1
Patient Compliance
1
Pain
1
Ovarian Neoplasms
1
Obesity
1
Lethal Congenital Contracture Syndrome 2
1
Joint Diseases
1
Invasive Breast Cancer
1
Hypogonadism
1
Granulosa Cell Ovarian Cancer
1
Fractures, Bone
1
Erectile Dysfunction
1
Epilepsy
1
Bone Diseases, Metabolic
1
Bone Density
1
Interventions
vistusertib
1
ribociclib
1
Tamoxifen
1
Letrozole
1
Goserelin
1
Fulvestrant
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Advanced Metastatic Breast Cancer
×
Anastrozole
×
Clear all
NCT02278120
2024-03-12
MONALEESA-7
Novartis
Phase 3
Completed
672 enrolled
16 charts
1 FDA